Cleveland HeartLab

Cleveland, United States Founded: 2008 • Age: 18 yrs Acquired By Quest Diagnostics
Cardiovascular biomarkers are utilized for disease prevention and management.
Request Access

About Cleveland HeartLab

Cleveland HeartLab is a company based in Cleveland (United States) founded in 2008 was acquired by Quest Diagnostics in October 2017.. Cleveland HeartLab has raised $38.85 million across 4 funding rounds from investors including Quest Diagnostics, Mutual Capital Partners and Excel Venture Management. Cleveland HeartLab operates in a competitive market with competitors including Conavi, Acarix, Ionetix, Infraredx and Kaminari Medical, among others.

  • Headquarter Cleveland, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cleveland Heartlab, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $38.85 M (USD)

    in 4 rounds

  • Latest Funding Round
    $2.75 M (USD), Series B

    Jul 08, 2014

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Quest Diagnostics

    (Oct 19, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Cleveland HeartLab
Headcount 50-200
Employee Profiles 14
Employee Profiles
People
Ryan McCoy
Director of Product Development
People
Kimberly Cannella
Client Operations Manager
People
Todd Hill
Cardiometabolic Sales Executive
People
Jayme Baker
Phlebotomist / Lab Technician

Unlock access to complete

Funding Insights of Cleveland HeartLab

Cleveland HeartLab has successfully raised a total of $38.85M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2.75 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series B — $2.8M
  • First Round

    (02 Mar 2010)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2014 Amount Series B - Cleveland HeartLab Valuation

investors

Oct, 2012 Amount Series B - Cleveland HeartLab Valuation

investors

Aug, 2011 Amount Series B - Cleveland HeartLab Valuation Excel Venture Management , Healthcare Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cleveland HeartLab

Cleveland HeartLab has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Quest Diagnostics, Mutual Capital Partners and Excel Venture Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Early to late stage VC firm investing in the US
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cleveland HeartLab

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cleveland HeartLab

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cleveland Heartlab Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cleveland HeartLab

Cleveland HeartLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conavi, Acarix, Ionetix, Infraredx and Kaminari Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Catheter-based ultrasound systems for cardiac imaging are developed.
domain founded_year HQ Location
A screening device for acoustic coronary artery diseases is provided.
domain founded_year HQ Location
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
domain founded_year HQ Location
Coronary imaging and plaque detection system
domain founded_year HQ Location
Developer of diagnostic solution for vulnerable plaque in the coronary arteries
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cleveland Heartlab

Frequently Asked Questions about Cleveland HeartLab

When was Cleveland HeartLab founded?

Cleveland HeartLab was founded in 2008 and raised its 1st funding round 2 years after it was founded.

Where is Cleveland HeartLab located?

Cleveland HeartLab is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.

Is Cleveland HeartLab a funded company?

Cleveland HeartLab is a funded company, having raised a total of $38.85M across 4 funding rounds to date. The company's 1st funding round was a Series B of $18.4M, raised on Mar 02, 2010.

What does Cleveland HeartLab do?

Cleveland HeartLab is a specialty clinical laboratory and disease management company focused on biomarker technologies. Offers a group of biomarkers that provide insight into an individuals risk for cardiovascular diseases. Has developed a profile of tests focused on managing and reducing inflammation along with range of standard and advanced tests. Has one U.S. Food and Drug Administration-approved test that detects an enzyme called myeloperoxidase, or MPO, in the blood.CAP-accredited and CLIA-certified clinical reference laboratory. Covers North America and Europe.

Who are the top competitors of Cleveland HeartLab?

Cleveland HeartLab's top competitors include Conavi, Acarix and Infraredx.

Who are Cleveland HeartLab's investors?

Cleveland HeartLab has 7 investors. Key investors include Quest Diagnostics, Mutual Capital Partners, Excel Venture Management, Healthcare Ventures, and Second Generation Ltd..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available